Dr. David Liang, MD

Dr. Liang practices at Encompass Health Rehabilitation Hospital of Fredericksburg in Fredericksburg, Virginia, part of Encompass Health.

Dr. Liang's NPI, 1114457645, was assigned on June 18, 2017. Dr. Liang holds Pennsylvania license MD481080.

Dr. Liang's primary practice is Encompass Health Rehabilitation Hospital of Fredericksburg, at 300 Park Hill Drive, Fredericksburg, VA 22401 in Fredericksburg City. The practice phone is (540) 368-7300.

Dr. Liang's primary practice is Encompass Health Rehabilitation Hospital of Fredericksburg in Fredericksburg, Virginia, part of Encompass Health. Dr. Liang is also affiliated with St. Mary Rehabilitation Hospital. The medical group on file is National Health Rehabilitation. Dmand AI also links Dr. Liang to 1 more physician office, 1 group practice or clinic, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liang practices, 5 sites in all. Vendor and product names are available with a free account.

Physical medicine and rehabilitation is Dr. Liang's primary specialty in the NPI Registry, under taxonomy code 208100000X. Dmand AI has Dr. Liang's licenses on file in 2 states: Pennsylvania and Virginia.

CMS data shows 7,298 Medicare services from Dr. Liang across 3 procedure codes in 2024, for 696 Medicare patients. Medicare paid $505,618 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 696 Medicare patients who saw Dr. Liang in 2024. The largest group is 75 to 84, with 260 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 62% are also on Medicaid. Their average risk score is 2.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Liang's median patient age at 78, with 51% women.

In 2024, Dr. Liang wrote 718 Medicare Part D claims for 147 patients. 96% of them were for generic drugs. CMS names the drug for 628 of them, across 12 drugs with 11 or more claims each, at $24,377 in total drug cost. In 2023, CMS named 188 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Liang for performance year 2024, reported as part of a group. Dr. Liang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Liang from 2 drug and device companies from 2021 to 2022. Food and beverage make up the largest share, 100% of the total. Relypsa, Inc. paid the most, $21.